← All Market Monitors SANOR About SANOR
GLP-1 Market Monitor

Lilly Expands Executive Leadership Responsibilities

Updated 20 September 2026

What Is Happening

Lilly announced an expanded role for Daniel Skovronsky as chief scientific and product officer, overseeing research and development alongside launches and product strategy in cardiometabolic health, immunology and neuroscience. He continues to report to chair and CEO David Ricks.

Sources (1)

Companies Involved

Eli Lilly

Pharmaceutical manufacturer

Eli Lilly develops and manufactures medicines for diabetes, obesity, cancer and other diseases.

Market cap $1.1tn

People Involved

Portrait unavailable

David Ricks

Chair & Chief Executive Officer

David Ricks leads Eli Lilly as chair and chief executive officer.

Portrait unavailable

Daniel Skovronsky

Chief Scientific & Product Officer

Daniel Skovronsky leads research and development at Eli Lilly and serves as president of Lilly Research Laboratories.

Mentioned In

GLP-1 Market Monitor

Updated 6 days ago

Ticker activity
$79.0bnAnnual market size
9.17%Forecast annual growth (CAGR)2025–2035

Active companies

Free Playbook

The Private Clinic Playbook

Grow revenue at each location and build a commercial model that can scale across a clinic group.

Sanor never sells your personal information. By providing this information you agree to Sanor’s Privacy Policy and Terms of Service.

Privacy Policy Terms of Service Disclaimer Sitemap

SANOR research follows the principles of ISO 20252:2019 and the ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics, and is conducted in line with our Independence Policy. Our published reports follow our Editorial Standards.

SANOR research is funded through advisory engagements and research licensing. We do not accept vendor sponsorship, paid placement, or advertising.

All publications are provided for general information only. They do not constitute medical, financial, or investment advice and do not account for the circumstances of any specific business or individual.

© 2026 SANOR Intelligence